Our Stories
Our Stories
-
Samsung Bioepis 2025 Year in Review: Shaping the Next Chapter in Biosimilar...
09/12/2025
-
[Re:Access] Stakeholders Hold the Key to Unlocking Biosimilar Potential
02/12/2025
-
[Re:Access] Biosimilar Regulation is Improving, But Still Needs Work
03/11/2025
-
Samsung Bioepis Welcomes FDA's Move to Accelerate Biosimilar Development
31/10/2025
-
Samsung Bioepis Wins ‘Biosimilar Initiative of the Year’ at the Global Gene...
31/10/2025
-
[Re:Access] Why Biosimilars are Vital to Sustaining Healthcare Systems
02/10/2025
